Addis count
Addis count is a medical test used to measure the number of red blood cells (RBCs), white blood cells (WBCs), and casts present in urine. Named after the British physician Thomas Addis, the test is primarily used in the diagnosis and management of kidney disease.
History[edit]
The Addis count was developed by Thomas Addis, a pioneer in the field of nephrology. Addis was a strong advocate for non-invasive diagnostic methods, and his test was one of the first to provide detailed information about kidney function without the need for surgery or other invasive procedures.
Procedure[edit]
The Addis count is performed on a 12-hour urine sample. The patient is instructed to void at the start of the period, discard this specimen, and then collect all urine produced over the next 12 hours. The sample is then sent to a laboratory for analysis.
In the lab, the urine is mixed and a small amount is placed on a slide. The slide is examined under a microscope, and the number of RBCs, WBCs, and casts are counted. The results are usually reported as the number of cells or casts per milliliter of urine.
Interpretation[edit]
The Addis count can provide valuable information about the health of the kidneys. An increased number of RBCs may indicate glomerulonephritis or other forms of kidney disease. An increased number of WBCs may suggest a urinary tract infection or pyelonephritis. The presence of casts, which are clumps of protein or cells, can also indicate kidney disease.
Limitations[edit]
While the Addis count can provide valuable information, it is not without limitations. The test requires a 12-hour urine collection, which can be inconvenient for the patient. In addition, the results can be influenced by factors such as hydration status and physical activity.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian